+953.8%
RKLB vs CVS
+32.3%
+921.5%
-69.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -10.9% | +1.0% | -11.9% | -11.1% |
| 7D | -26.2% | -9.5% | -16.7% | -24.8% |
| 30D | -15.4% | -12.9% | -2.5% | -13.4% |
| 3M | -37.7% | -13.1% | -24.7% | -36.4% |
| 6M | -66.2% | -12.2% | -54.0% | -65.7% |
| YTD | -34.9% | +5.0% | -39.9% | -36.7% |
| 1Y | +15.0% | +9.6% | +5.5% | +10.9% |
| 3Y | +953.8% | +32.6% | +921.2% | +855.7% |
| All | +953.8% | +32.3% | +921.5% | +855.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling